Surgical Science Sweden AB (publ)
SUS
Rank in Stocks
#14505
Surgical Science Sweden AB (publ) specializes in the creation and distribution... Surgical Science Sweden AB (publ) specializes in the creation and distribution of virtual reality (VR) simulation platforms designed for evidence-backed training in laparoscopic and endoscopic procedures. Among its key offerings is the LapSim training system, which includes LapSim ST, tailored for educating surgical technologists and assistants, as well as LapSim essence, a compact and readily deployable VR simulator. The company's product portfolio further extends to the EndoSim system, a dedicated endoscopy simulator for comprehensive medical training. It also features TeamSim, an innovative platform fostering inter-professional education by integrating surgical simulation with real-world team dynamics. Additionally, they provide the Simball Box, which delivers velocity feedback alongside instructional task videos demonstrating optimal techniques, alongside their well-known Simbionix and robotic surgery simulators. Established in 1999, Surgical Science AB maintains its headquarters in Gothenburg, Sweden.
Share Price
$6.26
Last synced: 2026-11-09
Market Cap
$319.39M
Change (1 day)
0.43%
Change (1 year)
-28.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Surgical Science Sweden AB (publ) (SUS)
Category
Healthcare
EPS for Surgical Science Sweden AB (publ) (SUS)
EPS as of June 2026 TTM: $0.18
According to Surgical Science Sweden AB (publ)'s latest financial reports, its current EPS (TTM) is $0.18. At the end of 2025 the company had an EPS of $0.14, a decrease compared to its 2024 EPS of $0.23.
EPS history for Surgical Science Sweden AB (publ) from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.18 | 31.93% |
| 2025 | $0.14 | -39.29% |
| 2024 | $0.23 | -48.59% |
| 2023 | $0.46 | 28.24% |
| 2022 | $0.35 | 58.18% |
| 2021 | $0.22 | 311.56% |
| 2020 | $0.05 | 13.07% |
| 2019 | $0.05 | -326.29% |
| 2018 | $-0.02 | 44.90% |
| 2017 | $-0.01 | -158.10% |
| 2016 | $0.03 | 224.36% |
| 2015 | $0.01 | -129.00% |
| 2014 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | 1,989.88% |
US
|
|
| $-1.05 | -668.49% |
US
|
|
| $1.79 | 870.38% |
AU
|
|
| $1.64 | 787.93% |
US
|
|
| $2.08 | 1,026.15% |
US
|
Questions about Surgical Science Sweden AB (publ)'s earnings per share (EPS)
What is Surgical Science Sweden AB (publ)'s earnings per share (EPS)?
Surgical Science Sweden AB (publ)'s earnings per share (EPS) over the last twelve months is $0.18, as of Jun 2026.
What was Surgical Science Sweden AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Surgical Science Sweden AB (publ)'s earnings per share (EPS) was $0.14, 39.13% less than in 2024 ($0.23).
How has Surgical Science Sweden AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Surgical Science Sweden AB (publ)'s earnings per share (EPS) went from $0.05 to $0.14, an average growth of 22.87% a year.
How does Surgical Science Sweden AB (publ)'s earnings per share (EPS) compare with similar companies?
Surgical Science Sweden AB (publ)'s earnings per share (EPS) ($0.18) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.